Susquehanna International Group, LLP Forma Therapeutics Holdings, Inc. Transaction History

Susquehanna International Group, LLP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$7.12 - $20.24 $588,432 - $1.67 Million	-82,645 Reduced 85.83%	13,647 $272,000
Q2 2022 Aug 15, 2022	BUY	$5.1 - $10.0 $177,658 - $348,350	34,835 Added 56.68%	96,292 $663,000
Q1 2022 May 16, 2022	BUY	$8.34 - $14.69 $68,079 - $119,914	8,163 Added 15.32%	61,457 $572,000
Q4 2021 Feb 14, 2022	BUY	$13.6 - $24.89 $309,794 - $566,969	22,779 Added 74.65%	53,294 $758,000
Q3 2021 Nov 15, 2021	SELL	$21.22 - $25.7 $117,516 - $142,326	-5,538 Reduced 15.36%	30,515 $708,000
Q2 2021 Aug 11, 2021	SELL	$22.86 - $30.95 $484,380 - $655,799	-21,189 Reduced 37.02%	36,053 $897,000
Q1 2021 May 17, 2021	BUY	$24.58 - $42.82 $1.22 Million - $2.12 Million	49,608 Added 649.83%	57,242 $1.6 Million
Q4 2020 Feb 16, 2021	BUY	$34.9 - $51.08 $266,426 - $389,944	7,634 New	7,634 $266,000

26.5K

Ticker FMTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,860,400
Market Cap $958M
Description
Forma Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on development and commercialization of novel therapeutics for treatment of rare hematologic diseases and cancers. Its core product candidates for development include FT-4202, which is Phase 1 trial for the treatment of sickle cell disease and other hemoglobin...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.